Extended screen time is reducing the normal blink rate by 60%, contributing to dry eye syndrome, a doctor has said following office workers reporting concerns over screen time-related health issues. A
The University of Auckland’s 2019 Excellence in Ophthalmology and Vision Research awards evening was planned as a special night marking 20 years since the awards began and the rise and rise of ophthalmology and vision research in New Zealand.
NVision Eyecare has opened for business in Albany on Auckland’s North Shore. Specialising in myopia control, rigid gas permeable (RGP) lens fitting and dry eye management, the practice is focusing on speciality eye care, and is the first to offer LipiFlow thermal pulsation to treat meibomian gland d
Eyelashes exist to help protect the ocular surface, but can certainly cause problems, from trivial to very serious. Worldwide, trachoma is one of the leading causes of blindness, essentially caused
Auckland University’s School of Optometry and Vision Science (SOVS) hosted a large audience for Dr Art Epstein’s alternative take on dry eye, garnered over many years of practice in one of the driest places on earth, Phoenix, Arizona.
This year’s CCLS’ sponsors exhibition was buzzing between talks, with attendees keen to hear what’s new and what’s coming. Here are some of the highlights:
Patients diagnosed with migraine headaches are at least 20% more likely to have dry eye disease (DED) than those without migraines, according to a study by University of North Carolina
Arizona optometrist Dr Arthur Epstein is listed by Optometric Management as among the most influential in optometry in the world today. A native New Yorker who grew up in the Bronx, Dr Epstein heads Phoenix Eye Care’s dry eye and ocular surface disease centre and drives its clinical research. He is
The Adelaide convention centre, with its mega floor to ceiling windows overlooking Adelaide’s stunning Riverbank Precinct and River Torrens was a pleasant surprise after so many walled in conference venues. The RANZCO 2018 exhibition room was also light and airy and hosted a hive of seemingly consta
Johnson & Johnson Vision hosted a continuing education evening in Wellington to discuss Meibomian gland dysfunction (MGD) treatment and the Tecnis Symfony Intraocular lens (IOL). It was open to ophthalmologists, nurses and optometrists and it was great to see a mix of these professions in the ro
Oyster Point Pharma says two separate Phase 2b clinical trials evaluating the company’s novel therapies for the treatment of Dry Eye Disease (DED) have demonstrated improvement in Schirmer’s score and
A few months ago I was supervising a 5th year optometry student’s primary care clinic. It was a simple dry eye follow up. The patient Josh (not his real name) was a 26-year-old male economics student, who one could say erred on the side of being a pedantic hypochondriac. Nevertheless, the persisting